Related Experiment Videos
Endogenous peptide(s) inhibiting [3H]cocaine binding in mouse brain
Neurochemical Research
|December 1, 1980
Summary
Researchers identified a low molecular weight peptide in mouse brain tissue that inhibits cocaine binding to brain membranes. This peptide affects opiate and nonopiate receptors, suggesting a novel neuromodulator role.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Brain tissue contains substances affecting neurotransmitter receptor binding.
- Cocaine's interaction with brain membranes is a key area of neuropharmacological research.
Purpose of the Study:
- To identify and characterize substances in brain tissue that inhibit [3H]cocaine binding.
- To investigate the nature and receptor interactions of this inhibitory substance.
Main Methods:
- Supernatant fraction of brain homogenate was prepared.
- Purification involved heat treatment, Amicon ultrafiltration, and Sephadex G-25 gel filtration.
- Inhibitory activity was assessed by [3H]cocaine binding assays and receptor interaction studies.
Main Results:
- A low molecular weight peptide inhibitor of [3H]cocaine binding was isolated.
- The inhibitor's sensitivity to acid hydrolysis and peptidases confirmed its peptide nature.
- The inhibitor demonstrated effects similar to cocaine on various opiate and nonopiate receptors.
Conclusions:
- Brain tissue contains a peptide inhibitor of cocaine binding.
- This peptide may play a role in modulating neurotransmitter receptor activity.
- Further research is warranted to elucidate the precise function of this endogenous peptide.